Max Robotics — Global Service Robot Directory + US Certification

About

Darryl Schuitevoerder is a surgical oncologist whose research focuses on improving outcomes in complex hepatopancreatobiliary (HPB) surgery, with a particular emphasis on minimally invasive techniques. His major contributions center on demonstrating the safety and efficacy of robotic pancreaticoduodenectomy (RPD) compared to traditional open surgery. Using rigorous propensity score matching with NSQIP data, Schuitevoerder showed that RPD significantly decreases the risk of clinically relevant post-operative pancreatic fistula, a dreaded complication, while also reducing overall complications. His work on bile leak incidence and risk factors following hepatectomy has further refined perioperative risk assessment. With his most cited papers accumulating over 95 citations, Schuitevoerder’s research provides critical evidence supporting the adoption of robotic approaches in HPB surgery. He has also contributed to the literature on rare conditions, such as intrapancreatic hepatocellular carcinoma, demonstrating his breadth as a surgeon-scientist. His findings help guide surgical decision-making and set standards for complication reduction in high-risk pancreatic and liver procedures.